Editorial

Georgios Schoretsanitis; Stefan Unterecker; Xenia M. Hart

doi:10.1055/a-2897-5020

July 6, 2026Pharmacopsychiatry

Editorial

View Full Paper

Ask AI

Bookmark

Share

Key Points

This editorial aims to highlight the importance of therapeutic drug monitoring in pharmacopsychiatry, particularly for antidepressants and antipsychotic medications.
Overview of therapeutic drug monitoring practices in psychiatry.
Discussion on pharmacogenetics related to antidepressant and antipsychotic drug use.
Emphasizes the critical role of individualized treatment based on drug monitoring.
Suggests enhanced patient outcomes through the integration of pharmacogenetic data in prescribing practices.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Editorial discusses the role of therapeutic drug monitoring in optimizing treatment with antidepressants and antipsychotic drugs, highlighting implications for pharmacogenetics.

Abstract

Keywords therapeutic drug monitoring - pharmacopsychiatry - antidepressants - antipsychotic drugs - pharmacogenetics Publication History Received: 11 June 2026 Accepted: 16 June 2026 Article published online: 06 July 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Schoretsanitis et al. (2026) studied this question.

synapsesocial.com/papers/6a4f39a72b81a944af574666 https://doi.org/10.1055/a-2897-5020

View Full Paper

Ask AI

Bookmark

Share

Editorial

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Editorial

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading